FDA Advisory Committee Votes in Support of Approval for Pfizer ’s Vaccine Candidate to Help Prevent RSV in Infants Through Maternal Immunization

NEW YORK--(BUSINESS WIRE) May 18, 2023 -- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that the available data support the...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials